These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 25804398)
41. The molecular basis of alkaptonuria. Fernández-Cañón JM; Granadino B; Beltrán-Valero de Bernabé D; Renedo M; Fernández-Ruiz E; Peñalva MA; Rodríguez de Córdoba S Nat Genet; 1996 Sep; 14(1):19-24. PubMed ID: 8782815 [TBL] [Abstract][Full Text] [Related]
42. Molecular diagnosis of alkaptonuria mutation by analysis of homogentisate 1,2 dioxygenase mRNA from urine and blood. Ramos SM; Hernández M; Roces A; Larruga JM; González P; González AM; Pinto FM; Cabrera VM Am J Med Genet; 1998 Jun; 78(2):192-4. PubMed ID: 9674916 [TBL] [Abstract][Full Text] [Related]
43. Homogentisate 1,2 dioxygenase is expressed in human osteoarticular cells: implications in alkaptonuria. Laschi M; Tinti L; Braconi D; Millucci L; Ghezzi L; Amato L; Selvi E; Spreafico A; Bernardini G; Santucci A J Cell Physiol; 2012 Sep; 227(9):3254-7. PubMed ID: 22105303 [TBL] [Abstract][Full Text] [Related]
44. Mutational analysis of the HGO gene in Finnish alkaptonuria patients. Beltrán-Valero de Bernabé D; Peterson P; Luopajärvi K; Matintalo P; Alho A; Konttinen Y; Krohn K; Rodríguez de Córdoba S; Ranki A J Med Genet; 1999 Dec; 36(12):922-3. PubMed ID: 10594001 [TBL] [Abstract][Full Text] [Related]
45. Mutation and polymorphism analysis of the human homogentisate 1, 2-dioxygenase gene in alkaptonuria patients. Beltrán-Valero de Bernabé D; Granadino B; Chiarelli I; Porfirio B; Mayatepek E; Aquaron R; Moore MM; Festen JJ; Sanmartí R; Peñalva MA; de Córdoba SR Am J Hum Genet; 1998 Apr; 62(4):776-84. PubMed ID: 9529363 [TBL] [Abstract][Full Text] [Related]
46. Ochronotic rheumatism in Algeria: clinical, radiological, biological and molecular studies--a case study of 14 patients in 11 families. Ladjouze-Rezig A; Rodriguez de Cordoba S; Aquaron R Joint Bone Spine; 2006 May; 73(3):284-92. PubMed ID: 16085442 [TBL] [Abstract][Full Text] [Related]
47. Metabolomic studies in the inborn error of metabolism alkaptonuria reveal new biotransformations in tyrosine metabolism. Norman BP; Davison AS; Hughes JH; Sutherland H; Wilson PJ; Berry NG; Hughes AT; Milan AM; Jarvis JC; Roberts NB; Ranganath LR; Bou-Gharios G; Gallagher JA Genes Dis; 2022 Jul; 9(4):1129-1142. PubMed ID: 35685462 [TBL] [Abstract][Full Text] [Related]
48. The human gene for alkaptonuria (AKU) maps to chromosome 3q. Janocha S; Wolz W; Srsen S; Srsnova K; Montagutelli X; Guénet JL; Grimm T; Kress W; Müller CR Genomics; 1994 Jan; 19(1):5-8. PubMed ID: 8188241 [TBL] [Abstract][Full Text] [Related]
49. Redox proteomics gives insights into the role of oxidative stress in alkaptonuria. Braconi D; Millucci L; Ghezzi L; Santucci A Expert Rev Proteomics; 2013 Dec; 10(6):521-35. PubMed ID: 24206226 [TBL] [Abstract][Full Text] [Related]
50. R58fs mutation in the HGD gene in a family with alkaptonuria in the UAE. Abdulrazzaq YM; Ibrahim A; Al-Khayat AI; Nagelkerke N; Ali BR Ann Hum Genet; 2009 Jan; 73(1):125-30. PubMed ID: 18945288 [TBL] [Abstract][Full Text] [Related]
52. Long-term follow-up of alkaptonuria patients: single center experience. Bozaci AE; Yazici H; Canda E; Uçar SK; Guvenc MS; Berdeli A; Habif S; Coker M J Pediatr Endocrinol Metab; 2022 Jul; 35(7):913-923. PubMed ID: 35671204 [TBL] [Abstract][Full Text] [Related]
53. Sequence analysis of the homogentisate 1,2 dioxygenase gene in a family affected by alkaptonuria. Walter K; Gaa A; Schaefer HE J Med Genet; 1999 Aug; 36(8):645-6. PubMed ID: 10465119 [No Abstract] [Full Text] [Related]
54. A molecular spectroscopy approach for the investigation of early phase ochronotic pigment development in Alkaptonuria. Bernini A; Petricci E; Atrei A; Baratto MC; Manetti F; Santucci A Sci Rep; 2021 Nov; 11(1):22562. PubMed ID: 34799606 [TBL] [Abstract][Full Text] [Related]
55. Alkaptonuria: a very rare metabolic disorder. Aquaron R Indian J Biochem Biophys; 2013 Oct; 50(5):339-44. PubMed ID: 24772955 [TBL] [Abstract][Full Text] [Related]
58. Ochronotic osteoarthropathy in a mouse model of alkaptonuria, and its inhibition by nitisinone. Preston AJ; Keenan CM; Sutherland H; Wilson PJ; Wlodarski B; Taylor AM; Williams DP; Ranganath LR; Gallagher JA; Jarvis JC Ann Rheum Dis; 2014 Jan; 73(1):284-9. PubMed ID: 23511227 [TBL] [Abstract][Full Text] [Related]
59. Identification of Potential Inhibitors for the Treatment of Alkaptonuria Using an Integrated In Silico Computational Strategy. Zaib S; Rana N; Hussain N; Ogaly HA; Dera AA; Khan I Molecules; 2023 Mar; 28(6):. PubMed ID: 36985595 [TBL] [Abstract][Full Text] [Related]
60. Analysis of the Phenotype Differences in Siblings with Alkaptonuria. Zatkova A; Olsson B; Ranganath LR; Imrich R Metabolites; 2022 Oct; 12(10):. PubMed ID: 36295892 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]